Phathom Pharmaceuticals, Inc. PHAT Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s operating lease ROU assets?
- Phathom Pharmaceuticals, Inc. (PHAT) reported operating lease ROU assets of $2.51M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s operating lease ROU assets changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s operating lease ROU assets increased by 546.4% year-over-year, from $388K to $2.51M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s operating lease ROU assets has grown at a 1.9% compound annual growth rate (CAGR), from $2.37M to $2.6M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.